Why our salt addiction is hard to kick
Americans love salt. And we eat too much of it. So much so that the Food and Drug Administration (FDA) is thinking about limiting the amount of sodium in packaged foods.
Walgreens delays DNA tests sales
Walgreens has postponed its plans to sell personal genetic test kits after the Food and Drug Administration intervened.
Takeda renames heartburn drug to avoid errors (AP)
AP - Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.
FDA warning for hand sanitizer in Puerto Rico (AP)
AP - The U.S. Food and Drug Administration is warning consumers in Puerto Rico that two locally produced hand sanitizers contain high levels of bacteria.
Glaxo defends handling of Avandia heart risks (AP)
AP - GlaxoSmithKline said Wednesday a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record.
Extended-Release Mirapex Approved for Parkinson’s Disease (HealthDay)
HealthDay - WEDNESDAY, Feb. 24 (HealthDay News) -- Mirapex ER (pramipexole
dihydrochloride extended-release) has been approved by the U.S. Food and
Drug Administration as a once-daily option to treat early Parkinson's
disease, drug maker Boehringer Ingelheim said in a news release.
FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market (HealthDay)
HealthDay - MONDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug
Administration on Monday said it was still reviewing documents that
examine whether the blockbuster type 2 diabetes drug Avandia raises users'
odds for heart attack and heart failure and should be removed from the
market.
Report: Avandia, heart attacks linked
The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline worked to keep the risks from the public, a Senate committee report says.
U.S. reviewers urge Glaxo’s Avandia come off market (Reuters)
Reuters - Two U.S. drug safety reviewers have recommended that GlaxoSmithKline PLC's diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, according to documents released on Saturday.
Rituxan Approved for Chronic Lymphocytic Leukemia (HealthDay)
HealthDay - FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been
approved by the U.S. Food and Drug Administration to treat a slowly
progressing form of blood and bone marrow cancer known as chronic
lymphocytic leukemia (CLL), the agency said in a press release.
Salmon OK to eat, FDA says
The Food and Drug Administration says Chilean salmon is still safe to consume despite a virus that has killed scores of fish.
